Answers are grounded in this paper and cite their sources.
Reviews clinical management and emerging precision medicine strategies for acute respiratory distress syndrome, highlighting phenotypic approaches to improve patient outcomes.
Acute respiratory distress syndrome (ARDS) is a common cause of acute hypoxemic respiratory failure in patients with pneumonia, sepsis, aspiration of gastric contents, severe trauma, or other inciting triggers. Although the definition of the syndrome has evolved over the past several decades, the core elements (acute onset, hypoxemia, and bilateral radiographic opacities) remain consistent. Critical components of management include identification and treatment of the underlying cause of ARDS as well as avoidance of ventilator-induced lung injury and volume overload. Ongoing areas of controversy include the best strategy for supporting nonintubated patients, personalization of positive end-expiratory pressure, the role of innovative ventilatory strategies, and the use of glucocorticoids. New research suggests that precision medicine approaches to ARDS management that focus on discrete biologic, radiographic, or physiological subphenotypes may improve outcomes, and prospective trials of these approaches are ongoing.
No takes yet. Share an insight, caveat, or question.
Calfee et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: